Morepen Laboratories (NSE:MOREPENLAB) 3-Year EBITDA Growth Rate : -0.30% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Morepen Laboratories 3-Year EBITDA Growth Rate?

Morepen Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was ₹1.08.

During the past 12 months, Morepen Laboratories's average EBITDA Per Share Growth Rate was 35.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -0.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 9.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Morepen Laboratories was 98.40% per year. The lowest was -32.00% per year. And the median was 11.10% per year.

Competitive Comparison of Morepen Laboratories's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Morepen Laboratories's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's 3-Year EBITDA Growth Rate falls into.

Morepen Laboratories 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Morepen Laboratories (NSE:MOREPENLAB) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Morepen Laboratories 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Morepen Laboratories (NSE:MOREPENLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (NSE:MOREPENLAB) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

500288:India

Address

2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, HR, IND, 122016

Website

https://www.morepen.com

Morepen Laboratories Ltd is an India based pharmaceutical company. It develops, manufactures and markets generic drugs and pharmaceutical formulations. The company's products includes Tablets, Capsules, Injections, Ointments, Syrups, and Powders. It also offers products under brands Burnol, Lemolate and Fiber-X. The company's geographical markets include India, the United States and the rest of the world, with a majority of revenue being generated in India.

Morepen Laboratories (NSE:MOREPENLAB) Headlines

No Headlines